Nektar Therapeutics - Common Stock NKTR

Real-time stock analysis, institutional holdings, insider trades & more

Updated:

📰 NKTR Latest News

Last Updated: 2026.04.07 12:47:07
Recent Headlines
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR
GlobeNewsWire 2026-04-07 12:47 PM
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
GlobeNewsWire 2026-04-06 10:35 PM
NEKTAR THERAPEUTICS (NKTR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Nektar Therapeutics Investors of Upcoming Deadline
GlobeNewsWire 2026-03-26 12:26 PM
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit
PRNewswire 2026-03-26 2:59 AM
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR
GlobeNewsWire 2026-03-25 10:23 PM
Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PRNewswire 2026-03-25 9:10 PM
NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026
GlobeNewsWire 2026-03-25 3:11 PM
NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Allegedly Overstating Trial Integrity Prospects: Levi & Korsinsky
BusinessWire 2026-03-24 8:00 PM
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers – NKTR
GlobeNewsWire 2026-03-24 7:56 PM
Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm
GlobeNewsWire 2026-03-24 4:00 PM
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Nektar Therapeutics (NKTR)
GlobeNewsWire 2026-03-24 12:48 PM
Holzer & Holzer, LLC Reminds Investors of May 5, 2026 Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Nektar Therapeutics (NKTR) and Eos Energy Enterprises, Inc. (EOSE)
GlobeNewsWire 2026-03-24 12:00 PM
Robbins LLP Urges NKTR Stockholders Who Lost Money Investing in Nektar Therapeutics to Contact the Firm for Information About Leading the Class Action
PRNewswire 2026-03-24 2:09 AM
Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
GlobeNewsWire 2026-03-23 5:36 PM
Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR
PRNewswire 2026-03-23 6:10 AM
Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2025 on Thursday, March 12, 2026, After Close of U.S.-Based Financial Markets
PRNewswire 2026-02-26 11:00 PM
Nektar Therapeutics to Participate in Two Investor Conferences in March
PRNewswire 2026-02-24 11:00 PM